Cluster analysis of clinical, angiographic, and laboratory parameters in patients with ST-segment elevation
Oğuzhan Birdal1, Emrah İpek2, Mehmet Saygı3
1Department of Cardiology, Ataturk University, Erzurum, 25240, Turkey. droguzhanbirdal@gmail.com.
Insights
Hierarchical agglomerative clustering (HAC) identified two distinct patient groups in ST-segment elevation myocardial infarction (STEMI). Cluster 2 demonstrated a significantly higher mortality risk, suggesting HAC
Area of Science:
- Cardiology
- Machine Learning in Healthcare
- Biostatistics
Background:
- ST-segment elevation myocardial infarction (STEMI) is a severe manifestation of coronary artery disease.
- Accurate risk stratification is crucial for guiding STEMI treatment and discharge planning.
- Hierarchical agglomerative clustering (HAC) offers a novel machine learning approach for patient categorization.
Purpose of the Study:
- To investigate the utility of HAC in stratifying STEMI patients into distinct phenotypic clusters.
- To compare the clinical outcomes, specifically mortality, between the identified patient clusters.
Main Methods:
- A cohort of 3205 STEMI patients diagnosed between 2015 and 2023 was analyzed.
- Hierarchical agglomerative clustering (HAC) was applied to categorize patients into two distinct clusters.
- Outcomes, including mortality, were compared between the clusters using statistical analyses (chi-square, log-rank, Cox regression).
Main Results:
- STEMI patients were divided into Cluster 1 (2731 patients) and Cluster 2 (474 patients).
- Cluster 2 exhibited significantly higher mortality rates (23%) compared to Cluster 1 (5.4%) (P < 0.01).
- Survival analysis and Cox regression confirmed a substantially increased risk of death in Cluster 2 (HR = 3.51, P < 0.001), even after adjusting for age and sex.
Conclusions:
- Hierarchical agglomerative clustering (HAC) effectively categorizes STEMI patients into groups with differing prognoses.
- The HAC method shows potential as a predictive tool for one-month mortality in STEMI patients.
- This machine learning approach may aid in refining risk assessment and treatment strategies for STEMI.
Introduction:
ST-segment elevation myocardial infarction (STEMI) represents the most harmful clinical manifestation of coronary artery disease. Risk assessment plays a beneficial role in determining both the treatment approach and the appropriate time for discharge. Hierarchical agglomerative clustering (HAC), a machine learning algorithm, is an innovative approach employed for the categorization of patients with comparable clinical and laboratory features. The aim of the present study was to investigate the role of HAC in categorizing STEMI patients and to compare the results of these patients.
Methods:
A total of 3205 patients who were diagnosed with STEMI at the university hospital emergency clinic between 2015 and 2023 were included in the study. The patients were divided into 2 different phenotypic disease clusters using the HAC method, and their outcomes were compared.
Results:
In the present study, a total of 3205 STEMI patients were included; 2731 patients were in cluster 1, and 474 patients were in cluster 2. Mortality was observed in 147 (5.4%) patients in cluster 1 and 108 (23%) patients in cluster 2 (chi-square P value < 0.01). Survival analysis revealed that patients in cluster 2 had a significantly greater risk of death than patients in cluster 1 did (log-rank P < 0.001). After adjustment for age and sex in the Cox proportional hazards model, cluster 2 exhibited a notably greater risk of death than did cluster 1 (HR = 3.51, 95% CI = 2.71-4.54; P < 0.001).
Conclusion:
Our study showed that the HAC method may be a potential tool for predicting one-month mortality in STEMI patients.
More Related Videos
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
04:41Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Electrocardiogram
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
